# A New Parameter Derived From DSA to Evaluate Cerebral Perfusion

> **NCT03607565** · — · RECRUITING · sponsor: **Xi'an No.3 Hospital** · enrollment: 30000 (estimated)

## Conditions studied

- Cerebral Ischemia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03607565
- **Lead sponsor:** Xi'an No.3 Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2018-07-15
- **Primary completion:** 2028-07-15
- **Final completion:** 2038-07-15
- **Target enrollment:** 30000 (ESTIMATED)
- **Last updated:** 2023-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03607565

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03607565, "A New Parameter Derived From DSA to Evaluate Cerebral Perfusion". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03607565. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*